FDA grants emergency use authorization to Janssen COVID-19 vaccine

pharmanewsdaily- February 28, 2021 0

The US Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the Janssen COVID-19 Vaccine, Ad26.COV2.S, developed by Johnson & Johnson's ... Read More